Production (Stage)
IRadimed Corporation
IRMD
$57.88
-$0.26-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.32% | 13.37% | -0.35% | 17.26% | 21.44% |
| Total Depreciation and Amortization | -14.15% | -5.11% | 4.05% | 6.24% | 23.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.92% | -15.84% | 41.96% | -79.56% | 75.84% |
| Change in Net Operating Assets | -2.44% | 115.74% | 171.23% | 791.83% | -1,240.41% |
| Cash from Operations | 10.53% | 53.02% | 554.53% | 88.93% | -16.42% |
| Capital Expenditure | -1,266.41% | -424.57% | -1,136.61% | -454.40% | 95.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.57% | -164.22% | -53.93% | 21.99% | -29.24% |
| Cash from Investing | -718.15% | -383.04% | -813.78% | -235.66% | 92.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -84.47% | -- | -54.79% | -- |
| Repurchase of Common Stock | -82.00% | -25.58% | 43.31% | 34.19% | -28.06% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 72.90% | -- | -- | -- | 39.68% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 71.67% | -820.60% | -6,009.24% | -2,082.96% | 39.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.95% | -83.00% | 245.43% | 11.91% | 69.47% |